thiazoles has been researched along with l-165041 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwashita, A; Kita, Y; Matsuoka, N; Mihara, K; Moriguchi, A; Muramatsu, Y; Muramoto, M; Yamazaki, S; Yamazaki, T | 1 |
| Aoyama, A; Hashimoto, Y; Hirono, S; Ishizawa, M; Kasuga, J; Makishima, M; Miyachi, H; Nakagome, I; Ogura, M; Sako, K | 1 |
| Southgate, J; Varley, CL | 1 |
| Duarte, J; Galindo, P; Gómez-Guzmán, M; Haro, JM; Jiménez, R; López-Sepúlveda, R; Pérez-Vizcaíno, F; Quintela, AM; Romero, M; Sánchez, M; Zarzuelo, A; Zarzuelo, MJ | 1 |
| Adams, SM; Bright, JJ; Chearwae, W; Iams, W; Kanakasabai, S; Walline, CC | 1 |
| Berlinski, B; Doll, M; Gille, J; Hrgovic, I; Kaufmann, R; Kippenberger, S; Laubach, V; Meissner, M; Reichenbach, G | 1 |
| Kim, H; Kwak, HJ; Lee, KS; Lim, HJ; Park, HY; Park, JH | 1 |
| Bernd, A; Doll, M; Hrgovic, I; Kaufmann, R; Kippenberger, S; Meissner, M; Reichenbach, G; Starzinski-Powitz, A; Valesky, EM | 1 |
| Blokland, M; Bovee, TF; Essers, ML; Hamers, AR; Heskamp, HH; Kersten, S; Nielen, MW; van Ginkel, LA | 1 |
| Duarte, J; Jiménez, R; Pérez-Vizcaíno, F; Romero, M; Toral, M | 1 |
1 review(s) available for thiazoles and l-165041
| Article | Year |
|---|---|
Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Endothelium, Vascular; Fatty Acids; Gene Expression Regulation; Humans; Hypertension; Inflammation; Phenoxyacetates; PPAR delta; PPAR-beta; Rats; Rats, Inbred SHR; RGS Proteins; Sympathetic Nervous System; Thiazoles; Vasoconstriction; Vasodilation | 2017 |
9 other study(ies) available for thiazoles and l-165041
| Article | Year |
|---|---|
Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo.
Topics: Acetates; Animals; Brain; Brain Ischemia; Caspases; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Dopamine; Genes, Reporter; Humans; Ligands; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Parkinson Disease; Phenols; Phenoxyacetates; PPAR delta; Rats; Rats, Wistar; Substrate Specificity; Thiazoles | 2007 |
Design, synthesis, and evaluation of potent, structurally novel peroxisome proliferator-activated receptor (PPAR) delta-selective agonists.
Topics: Animals; Binding Sites; Butyrates; Cell Line; Eicosapentaenoic Acid; Humans; Hydrocarbons, Fluorinated; Male; Mice; Models, Molecular; Molecular Structure; Mutagenicity Tests; Phenoxyacetates; Phenylurea Compounds; PPAR delta; Thiazoles | 2007 |
Effects of PPAR agonists on proliferation and differentiation in human urothelium.
Topics: Cell Death; Cell Differentiation; Cell Proliferation; Cells, Cultured; ErbB Receptors; Fenofibrate; Gene Expression Regulation; Humans; Hydrazines; Peroxisome Proliferator-Activated Receptors; Phenoxyacetates; Signal Transduction; Thiazoles; Urothelium | 2008 |
Endothelium-dependent vasodilator effects of peroxisome proliferator-activated receptor beta agonists via the phosphatidyl-inositol-3 kinase-Akt pathway.
Topics: Anilides; Animals; Aorta; Chromones; Endothelium, Vascular; Enzyme Inhibitors; Humans; Male; Morpholines; Nitric Oxide; Nitric Oxide Synthase Type III; Phenoxyacetates; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; PPAR-beta; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Sulfones; Thiazoles; Thiophenes; Umbilical Veins; Vasodilation | 2010 |
Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis.
Topics: Animals; Cell Polarity; Cells, Cultured; Encephalomyelitis, Autoimmune, Experimental; Female; Interleukin-17; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenoxyacetates; PPAR delta; T-Lymphocytes, Helper-Inducer; Th1 Cells; Thiazoles | 2010 |
AP1-dependent repression of TGFα-mediated MMP9 upregulation by PPARδ agonists in keratinocytes.
Topics: Binding Sites; Cell Line; Cell Nucleus; Cells, Cultured; Electrophoretic Mobility Shift Assay; Gene Expression; Gene Expression Regulation; Humans; Keratinocytes; Male; Matrix Metalloproteinase 9; Phenoxyacetates; PPAR delta; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Thiazoles; Transcription Factor AP-1; Transforming Growth Factor alpha; Up-Regulation | 2011 |
The PPARδ ligand L-165041 inhibits VEGF-induced angiogenesis, but the antiangiogenic effect is not related to PPARδ.
Topics: Angiogenesis Inhibitors; Cell Cycle; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Cyclin A; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Human Umbilical Vein Endothelial Cells; Humans; Neovascularization, Physiologic; Phenoxyacetates; Phosphorylation; PPAR delta; Retinoblastoma Protein; RNA Interference; RNA, Small Interfering; Signal Transduction; Thiazoles; Vascular Endothelial Growth Factor A; Wound Healing | 2012 |
Ligand activation of peroxisome proliferator-activated receptor delta suppresses cathepsin B expression in human endothelial cells in a posttranslational manner.
Topics: 3' Untranslated Regions; Base Sequence; Cathepsin B; DEAD-box RNA Helicases; Endothelial Cells; Gene Expression; Gene Knockdown Techniques; Human Umbilical Vein Endothelial Cells; Humans; Ligands; MicroRNAs; Phenoxyacetates; PPAR delta; Protein Processing, Post-Translational; Ribonuclease III; RNA, Small Interfering; Thiazoles | 2012 |
Bioactivity screening and mass spectrometric confirmation for the detection of PPARδ agonists that increase type 1 muscle fibres.
Topics: Actins; Angiopoietin-Like Protein 4; Angiopoietins; Biological Assay; Cell Line, Tumor; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Limit of Detection; Mass Spectrometry; Muscle Fibers, Slow-Twitch; Phenoxyacetates; Polymerase Chain Reaction; PPAR delta; RNA, Messenger; Thiazoles | 2014 |